| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000024.txt","as_of":"2026-04-03T11:12:58.166696+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000024.txt","company":"UNITED THERAPEUTICS Corp","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000024.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_02e6c34d7b311fc3","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000024.txt","content_type":"text/plain","enriched_at":"2026-04-03T14:09:50.011659+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000024.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000024.txt","source_event_id":"evt_d2b507bf0962","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"163c091df8cf23d3","kind":"sec_filing","published_at":"20260402","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.9,"dates_mentioned":["2026-04-02","2026-03-31","2025-11-07","2026-12-31","2027-03-15"],"entities":[{"asset_class":"equity","name":"United Therapeutics Corp","relevance":"issuer","symbol":"UTHR","type":"company"},{"asset_class":"","name":"Martine Rothblatt","relevance":"reporting owner","symbol":"","type":"individual"}],"event_type":"listing","information_gaps":["No prior state of stock transactions provided for comparison."],"key_facts":["Form 4 filed on April 2, 2026","Reporting owner: Martine Rothblatt","Transactions executed under a 10b5-1 trading plan","Multiple trades at prices ranging from $574.55 to $590.36"],"numeric_claims":[{"label":"Total stock options exercised","value":"1,734,410"},{"label":"Expiration date of stock options","value":"March 17, 2027"}],"primary_claim":"Martine Rothblatt executed multiple stock transactions involving United Therapeutics Corp's common stock and stock options on March 31, 2026.","relevance_score":0.8,"sentiment":"neutral","source_quality":"high","summary":"United Therapeutics Corp filed a Form 4 on April 2, 2026, disclosing stock transactions by Martine Rothblatt, including the exercise and sale of stock options under a pre-arranged trading plan.","topics":["SEC filing","stock transactions","executive compensation"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 UNITED THERAPEUTICS Corp \u00b7 Filed 20260402","ticker":"UTHR","tickers":["UTHR"],"title":"UTHR filed 4","url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000024.txt"}... |